Cancer statistics, Siegel CA (2023) A cancer journal for clinicians-wiley online library. https://acsjournals.onlinelibrary.wiley.com/doi/full/https://doi.org/10.3322/caac.21763. Accessed 26 Jan 2023

Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. JNCI J Natl Cancer Inst 102(3):170–178. https://doi.org/10.1093/jnci/djp482

Article  PubMed  Google Scholar 

Groen EJ, Elshof LE, Visser LL et al (2017) Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31:274–283. https://doi.org/10.1016/j.breast.2016.09.001

Article  PubMed  Google Scholar 

Rashmi Kumar N, Berardi R, Abraham J, Aft R, Agnese D, Allison KH (2022) NCCN Guidelines Version 4.2022 Breast Cancer [Internet].

Patani N, Khaled Y, Al Reefy S, Mokbel K (2011) Ductal carcinoma in-situ: an update for clinical practice. Surg Oncol 20(1):e23–e31. https://doi.org/10.1016/j.suronc.2010.08.007

Article  PubMed  Google Scholar 

Trends in treatment patterns and outcomes for ductal carcinoma in situ | JNCI: Journal of the National Cancer Institute | Oxford Academic. https://academic.oup.com/jnci/article/107/12/djv263/2457723. Accessed 3 Feb 2023

Van Cleef A, Altintas S, Huizing M, Papadimitriou K, Van Dam P, Tjalma W (2014) Current view on ductal carcinoma in situ and importance of the margin thresholds: a review. Facts Views Vis ObGyn 6(4):210–218

PubMed  PubMed Central  Google Scholar 

Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720. https://doi.org/10.1200/JCO.2005.08.001

Article  PubMed  Google Scholar 

Society of surgical oncology | choosing wisely (2016) Published July 12 https://www.choosingwisely.org/societies/society-of-surgical-oncology/Accessed 3 Feb 2023

The American Society of Breast surgeons Official Statement. Consensus statement on axillary management for patients with in-situ and invasive breast cancer: a concise overview. https://www.breastsurgeons.org/docs/statements/management-of-the-axilla.pdf. Accessed 16 Mar 2023

de Paz C, Villanueva C, Bonev V, Senthil M et al (2017) Factors associated with underestimation of invasive cancer in patients with ductal carcinoma in situ: precautions for active surveillance. JAMA Surg 152(11):1007–1014. https://doi.org/10.1001/jamasurg.2017.2181

Article  Google Scholar 

Podoll MB, Reisenbichler ES, Roland L, Bruner A, Mizuguchi S, Sanders MAG (2018) Feasibility of the less is more approach in treating low-risk ductal carcinoma in situ diagnosed on core needle biopsy: ten-year review of ductal carcinoma in situ upgraded to invasion at surgery. Arch Pathol Lab Med 142(9):1120–1126. https://doi.org/10.5858/arpa.2017-0268-OA

Article  PubMed  Google Scholar 

Hogue JC, Morais L, Provencher L et al (2014) Characteristics associated with upgrading to invasiveness after surgery of a dcis diagnosed using percutaneous biopsy. Anticancer Res 34(3):1183–1191

PubMed  Google Scholar 

Karakatsanis A, Hersi AF, Pistiolis L et al (2019) Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study). Br J Surg 106(6):720–728. https://doi.org/10.1002/bjs.11110

Article  CAS  PubMed  Google Scholar 

McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213–5219. https://doi.org/10.1200/JCO.2008.16.3725

Article  PubMed  PubMed Central  Google Scholar 

Karakatsanis A, Olofsson H, Stålberg P, Bergkvist L, Abdsaleh S, Wärnberg F (2018) Simplifying logistics and avoiding the unnecessary in patients with breast cancer undergoing sentinel node biopsy. a prospective feasibility trial of the preoperative injection of super paramagnetic iron oxide nanoparticles. Scand J Surg 107(2):130–137. https://doi.org/10.1177/1457496917738867

Article  CAS  PubMed  Google Scholar 

Smith ME, Vitous CA, Hughes T, Shubeck SP, Jagsi R, Dossett LA (2020) Barriers and facilitators to de-implementation of the choosing wisely® guidelines for low-value breast cancer surgery. Ann Surg Oncol 27(8):2653–2663. https://doi.org/10.1245/s10434-020-08285-0

Article  PubMed  PubMed Central  Google Scholar 

Fan B, Pardo JA, Serres S et al (2020) Role of sentinel lymph node biopsy in microinvasive breast cancer. Ann Surg Oncol 27:4468–4473

Article  PubMed  Google Scholar 

Intra M, Veronesi P, Gentilini OD et al (2007) Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol 95(2):175–179. https://doi.org/10.1002/jso.20670

Article  PubMed  Google Scholar 

Karam A, Stempel M, Cody HS, Port ER (2008) Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg 207(4):543–548. https://doi.org/10.1016/j.jamcollsurg.2008.06.139

Article  PubMed  Google Scholar 

Karakatsanis A (2022) Sentinel lymph node biopsy in ductal cancer in situ or unclear lesions of the breast and how to not do it. an open-label, phase 3, randomised controlled trial (sentinot 2.0). clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT04722692. Accessed 16 Mar 2023